Journal for ImmunoTherapy of Cancer

Journal Title
Journal for ImmunoTherapy of Cancer

J IMMUNOTHER CANCER

ISSN / eISSN
2051-1426 / 2051-1426
Aims and Scope
Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.
Subject Area

IMMUNOLOGY

ONCOLOGY

CiteScore
17.70 View Trend
CiteScore Ranking
Category Quartile Rank
Pharmacology, Toxicology and Pharmaceutics - Pharmacology Q1 #11/313
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine Q1 #11/178
Pharmacology, Toxicology and Pharmaceutics - Oncology Q1 #25/404
Pharmacology, Toxicology and Pharmaceutics - Cancer Research Q1 #18/230
Pharmacology, Toxicology and Pharmaceutics - Immunology and Allergy Q1 #20/233
Pharmacology, Toxicology and Pharmaceutics - Immunology Q1 #23/236
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
IMMUNOLOGY Q1
ONCOLOGY Q1
H-index
36
Country/Area of Publication
UNITED STATES
Publisher
BioMed Central
Year Publication Started
2013
Annual Article Volume
417
Open Access
YES
Contact
BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND, WC1H 9JR

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search